Skip to main content
. 2016 Apr;28(2):150–160. doi: 10.21147/j.issn.1000-9604.2016.02.02

Table S1.

Characteristics of risk prediction models in CHB patients

Factors Risk predictors Prediction risk score in CHB patients (category)
GAG CU LSM REACH-B REACH-B (nomogram) Lin Lee Kim
No. of model 2 1 1 1 3 3 1 1
CHB, chronic hepatitis B; HBV, hepatitis B virus; HBeAg, hepatitis B e antigen; HBsAg, hepatitis B surface antigen; LSM, liver stiffness measure; ALT, alanine aminotransferase; AST, serum aspartate transaminase; AAR, AST/ALT ratio; AFP, alpha-fetoprotein; GGT, gamma-glutamyltransferase; *, HBeAg/HBV DNA level (copies/mL); **, HBeAg/HBV DNA level (copies/mL)/HBV genotype; ***, HBeAg/HBV DNA level (copies/mL); ****, HBeAg/HBV DNA level (copies/mL)/HBsAg(IU/mL)/HBV genotype.
Host factors Age Years entered as continuous variable Years entered as continuous variable 0 (≤50 years) 0 (≤50 years) 0 (30-34 years) 0 (30-34 years) 0 (30-34 years) 0 (30-34 years) 0 (40-44 years) 0 (40-44 years) 0 (40-44 years) 0 (30-34 years) 0 (≤50 years)
3 (>50 years) 10 (>50 years) 1 (5-year increments) 1 (5-year increments) 1 (5-year increments) 1 (5-year increments) 1 (5-year increments) 1 (5-year increments) 1 (5-year increments) 1 (5-year increments) 0.05306 (>50 years)
Gender 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female) 0 (female)
16 (male) 14 (male) 2 (male) 2 (male) 2 (male) 2 (male) 1 (male) 1 (male) 1 (male) 4 (male) 1.106 (male)
Family history 0 (no) 0 (no) 0 (no)
2 (yes) 2 (yes) 2 (yes)
Environmental factors Alcohol 0 (no) 0 (no) 0 (no)
1 (yes) 2 (yes) 2 (yes)
Virological factors HBeAg 0 (negative) 0 (negative) 0 [negative/<300 (undetectable)]* 0 [negative/<300 (undetectable)]** 0 (negative/≤10,000)*** 0 (negative/≤10,000)*** 0 (negative/<104/<100)****
2 (positive) 3 (positive) 1 (negative/300-9,999) 1 (negative/300-9,999 ) 3 (negative/>10,000) 3 (negative/>10,000) 2 (negative/<104/100-999)
HBV DNA (copies/mL in log)×3 entered as continuous variable (copies/mL in log)×3 entered as continuous variable 0 (≤4 log copies/mL) 0 (≤20,000 IU/mL) 0 (<9,999 copies/mL) 3 (negative/10,000-99,999) 3 (negative/10,000-99,999/B or B+C) 6 (positive) 5 (positive) 2 (negative/<104/≥1,000) 0 (≤20,000 IU/mL)
1 (4-6 log copies/mL) 5 (>20,000 IU/mL) 3 (10,000-99,999 copies/mL) 4 (negative/100,000-999,999) 4 (negative/10,000-99,999/C) 3 (negative/104-106/<100) 0.50969 (>20,000 IU/mL)
4 (>6 log copies/mL) 5 (100,000-999,999 copies/mL) 5 (negative/1,000,000) 3 (negative/100,000-999,999/B or B+C) 3 (negative/104-106/100-999)
4 (≥106 copies/mL) 6 (positive) 7 (negative/100,000-999,999/C ) 4 (negative/104-106/≥1,000)
HBV genotype 4 (negative/≥1,000,000/B or B+C ) 5 (negative/≥106/any level/B or B+C)
7 (negative/≥1,000,000/C ) 7 (negative/≥106/any level/C)
Quantitative serum HBsAg levels 6 (positive/B or B+C) 6 (positive/any level/any level/B or B+C)
6 (positive/C) 7 (positive/any level/any level/C)
Core promoter mutations 0 (wild-type)
19 (mutant)
Liver-related seromarkers Cirrhosis/LSM 0 (no) 0 (no) 0 (no) 0 (≤8.0 kPa) 0 (≤7.7 kPa)
30 (yes) 33 (yes) 15 (yes) 8 (8.1-12.0 kPa) 0.04858 (>7.7 kPa)
14 (>12.0 kPa)
Albumin 0 (>35 g/L) 0 (>35 g/L) 0 (>4.1 g/dL) 0 (>4.1 g/dL)
20 (≤35 g/L) 1 (≤35 g/L) 4 (≤4.1 g/dL) 3 (≤4.1 g/dL)
Bilirubin 0 (>18 μmol/L)
1.5 (≤18 μmol/L)
ALT 0 (<15 IU/L) 0 (<15 IU/L) 0 (<15 IU/L) 0 (<15 IU/L) 0 (<28 IU/L) 0 (<28 IU/L) 0 (<28 IU/L) 0 (<15 IU/L)
1 (15-44 IU/L) 1 (15-44 IU/L) 1 (15-44 IU/L) 1 (≥15 IU/L) 2 (≥28 IU/L) 5 (≥28 IU/L) 3 (≥28 IU/L) 1 (15-44 IU/L)
2 (≥45 IU/L) 3 (≥45 IU/L) 2 (≥45 IU/L) 3 (≥45 IU/L)
AAR 0 (<1) 0 (<1)
7 (≥1) 6 (≥1)
AFP 0 (<5 ng/mL) 0 (<5 ng/mL)
5 (≥5 ng/mL) 4 (≥5 ng/mL)
GGT 0 (<41 IU/L) 0 (<41 IU/L)
4 (≥41 IU/L) 4 (≥41 IU/L)
Alpha-1 globulin 0 (>0.2 g/dL) 0 (>0.2 g/dL)
2 (≤0.2 g/dL) 2 (≤0.2 g/dL)
Sum 0-43.5 0-30 0-17 0-17 0-20 0-20 0-15 0-33 0-33 0-19